Previous studies have shown that C3a/C3aR participates in the pathogenesis of FSGS by regulating various signaling pathways both in glomeruli and tubules, and mentioned the protective function of the C3aR blocker. This evidence concerns the gene C3 and focal segmental glomerulosclerosis.